We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Greenphire Appoints Chief Commercial Officer

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Greenphire Appoints Chief Commercial Officer"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Greenphire has announced the appointment of John M Blakeley to the role of Chief Commercial Officer.

Blakeley will lead Greenphire’s global marketing and sales strategy as the company continues to extend the adoption of its clinical payment technology platforms, the ClinCard System and the eClinicalGPS, to the pharmaceutical, medical device, and contract research markets.

Prior to joining Greenphire, Blakeley spent 10 years in senior management and executive roles at clinical service and medical device provider ERT, most recently serving as ERT’s Chief Commercial Officer.

“Greenphire is truly a rising star in our industry, unlike almost any young clinical technology company we’ve seen in the last decade,” said Blakeley.

Blakeley continued, “The team is motivated and savvy, and the technologies they’ve developed shift the global clinical payment paradigm on the same scale that EDC, IVR and ePRO have done for clinical data in years past. It’s a thrill for me, both professionally and personally, to continue to be at the cutting edge of technological innovation which will ultimately make drug development and medical discovery less expensive and more efficient.”

Greenphire CEO Sam Whitaker reciprocated Blakeley’s comment and shared his optimism with regards to the company’s future.

“John’s track record speaks for itself,” he said. “When John started at ERT it was still a relatively early-stage company, and the vision and leadership he exhibited in bringing clinical solutions to a global market is a model for any young company in our industry. John is an exemplary leader and an innovative thinker, and the Greenphire team is excited to work with him to further establish Greenphire as a pillar in the clinical research industry and the leader in clinical payment technologies.”